-
1
-
-
0002261078
-
A method for determining loss of pain sensation
-
D'Amour F., and Smith D. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72 (1941) 74-79
-
(1941)
J. Pharmacol. Exp. Ther.
, vol.72
, pp. 74-79
-
-
D'Amour, F.1
Smith, D.2
-
2
-
-
0030033533
-
Contribution of monoaminergic modulation to the analgesic effect of tramadol
-
Desmeules J.A., Piguet V., Collart L., and Dayer P. Contribution of monoaminergic modulation to the analgesic effect of tramadol. Br. J. Clin. Pharmacol. 41 (1996) 7-12
-
(1996)
Br. J. Clin. Pharmacol.
, vol.41
, pp. 7-12
-
-
Desmeules, J.A.1
Piguet, V.2
Collart, L.3
Dayer, P.4
-
3
-
-
0026585612
-
Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro
-
Driessen B., and Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br. J. Pharmacol. 105 (1992) 147-151
-
(1992)
Br. J. Pharmacol.
, vol.105
, pp. 147-151
-
-
Driessen, B.1
Reimann, W.2
-
4
-
-
0027511794
-
Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro
-
Driessen B., Reimann W., and Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br. J. Pharmacol. 108 (1993) 806-811
-
(1993)
Br. J. Pharmacol.
, vol.108
, pp. 806-811
-
-
Driessen, B.1
Reimann, W.2
Giertz, H.3
-
5
-
-
0033808357
-
Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats
-
Garrido M.J., Valle M., Campanero M.A., Calvo R., and Troconiz I.F. Modeling of the in vivo antinociceptive interaction between an opioid agonist, (+)-O-desmethyltramadol, and a monoamine reuptake inhibitor, (-)-O-desmethyltramadol, in rats. J. Pharmacol. Exp. Ther. 295 (2000) 352-359
-
(2000)
J. Pharmacol. Exp. Ther.
, vol.295
, pp. 352-359
-
-
Garrido, M.J.1
Valle, M.2
Campanero, M.A.3
Calvo, R.4
Troconiz, I.F.5
-
6
-
-
0023720412
-
Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids
-
Hennies H.H., Friderichs E., and Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 38 (1988) 877-880
-
(1988)
Arzneimittelforschung
, vol.38
, pp. 877-880
-
-
Hennies, H.H.1
Friderichs, E.2
Schneider, J.3
-
7
-
-
0024814788
-
Preferential stimulation of D1 or D2 receptors disrupts food-rewarded operant responding in rats
-
Hoffman D.C., and Beninger R.J. Preferential stimulation of D1 or D2 receptors disrupts food-rewarded operant responding in rats. Pharmacol. Biochem. Behav. 34 (1989) 923-925
-
(1989)
Pharmacol. Biochem. Behav.
, vol.34
, pp. 923-925
-
-
Hoffman, D.C.1
Beninger, R.J.2
-
8
-
-
4344698717
-
Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in micro-opioid receptor knockout mice
-
Ide S., Minami M., Satoh M., Uhl G.R., Sora I., and Ikeda K. Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in micro-opioid receptor knockout mice. Neuropsychopharmacology 29 (2004) 1656-1663
-
(2004)
Neuropsychopharmacology
, vol.29
, pp. 1656-1663
-
-
Ide, S.1
Minami, M.2
Satoh, M.3
Uhl, G.R.4
Sora, I.5
Ikeda, K.6
-
9
-
-
0032846612
-
Unique behavioural phenotypes of recombinant-inbred CXBK mice: partial deficiency of sensitivity to mu- and kappa-agonists
-
Ikeda K., Ichikawa T., Kobayashi T., Kumanishi T., Oike S., and Yano R. Unique behavioural phenotypes of recombinant-inbred CXBK mice: partial deficiency of sensitivity to mu- and kappa-agonists. Neurosci. Res. 34 (1999) 149-155
-
(1999)
Neurosci. Res.
, vol.34
, pp. 149-155
-
-
Ikeda, K.1
Ichikawa, T.2
Kobayashi, T.3
Kumanishi, T.4
Oike, S.5
Yano, R.6
-
10
-
-
0026564002
-
Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat
-
Kayser V., Besson J.M., and Guilbaud G. Evidence for a noradrenergic component in the antinociceptive effect of the analgesic agent tramadol in an animal model of clinical pain, the arthritic rat. Eur. J. Pharmacol. 224 (1992) 83-88
-
(1992)
Eur. J. Pharmacol.
, vol.224
, pp. 83-88
-
-
Kayser, V.1
Besson, J.M.2
Guilbaud, G.3
-
11
-
-
0027194499
-
Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states
-
Lee C.R., McTavish D., and Sorkin E.M. Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states. Drugs 46 (1993) 313-340
-
(1993)
Drugs
, vol.46
, pp. 313-340
-
-
Lee, C.R.1
McTavish, D.2
Sorkin, E.M.3
-
12
-
-
0032031040
-
mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality
-
Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., and Wei L.N. mu Opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Brain Res. Mol. Brain Res. 54 (1998) 321-326
-
(1998)
Brain Res. Mol. Brain Res.
, vol.54
, pp. 321-326
-
-
Loh, H.H.1
Liu, H.C.2
Cavalli, A.3
Yang, W.4
Chen, Y.F.5
Wei, L.N.6
-
14
-
-
0029852678
-
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene
-
Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., and Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 383 (1996) 819-823
-
(1996)
Nature
, vol.383
, pp. 819-823
-
-
Matthes, H.W.1
Maldonado, R.2
Simonin, F.3
Valverde, O.4
Slowe, S.5
Kitchen, I.6
Befort, K.7
Dierich, A.8
Le Meur, M.9
Dolle, P.10
Tzavara, E.11
Hanoune, J.12
Roques, B.P.13
Kieffer, B.L.14
-
15
-
-
17344370360
-
Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor
-
Matthes H.W., Smadja C., Valverde O., Vonesch J.L., Foutz A.S., Boudinot E., Denavit-Saubie M., Severini C., Negri L., Roques B.P., Maldonado R., and Kieffer B.L. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. J. Neurosci. 18 (1998) 7285-7295
-
(1998)
J. Neurosci.
, vol.18
, pp. 7285-7295
-
-
Matthes, H.W.1
Smadja, C.2
Valverde, O.3
Vonesch, J.L.4
Foutz, A.S.5
Boudinot, E.6
Denavit-Saubie, M.7
Severini, C.8
Negri, L.9
Roques, B.P.10
Maldonado, R.11
Kieffer, B.L.12
-
16
-
-
0031771510
-
Antinociception, tolerance, and physical dependence comparison between morphine and tramadol
-
Miranda H.F., and Pinardi G. Antinociception, tolerance, and physical dependence comparison between morphine and tramadol. Pharmacol. Biochem. Behav. 61 (1998) 357-360
-
(1998)
Pharmacol. Biochem. Behav.
, vol.61
, pp. 357-360
-
-
Miranda, H.F.1
Pinardi, G.2
-
17
-
-
0017836575
-
Studies on dependence on tramadol in rats
-
Murano T., Yamamoto H., Endo N., Kudo Y., Okada N., Masuda Y., and Yano I. Studies on dependence on tramadol in rats. Arzneimittelforschung 28 (1978) 152-158
-
(1978)
Arzneimittelforschung
, vol.28
, pp. 152-158
-
-
Murano, T.1
Yamamoto, H.2
Endo, N.3
Kudo, Y.4
Okada, N.5
Masuda, Y.6
Yano, I.7
-
18
-
-
0037066901
-
The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component
-
Oliva P., Aurilio C., Massimo F., Grella A., Maione S., Grella E., Scafuro M., Rossi F., and Berrino L. The antinociceptive effect of tramadol in the formalin test is mediated by the serotonergic component. Eur. J. Pharmacol. 445 (2002) 179-185
-
(2002)
Eur. J. Pharmacol.
, vol.445
, pp. 179-185
-
-
Oliva, P.1
Aurilio, C.2
Massimo, F.3
Grella, A.4
Maione, S.5
Grella, E.6
Scafuro, M.7
Rossi, F.8
Berrino, L.9
-
19
-
-
0031460240
-
Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol
-
Paar W.D., Poche S., Gerloff J., and Dengler H.J. Polymorphic CYP2D6 mediates O-demethylation of the opioid analgesic tramadol. Eur. J. Clin. Pharmacol. 53 (1997) 235-239
-
(1997)
Eur. J. Clin. Pharmacol.
, vol.53
, pp. 235-239
-
-
Paar, W.D.1
Poche, S.2
Gerloff, J.3
Dengler, H.J.4
-
20
-
-
0002725516
-
Differential effects of short-and long-term antidepressant treatments on the food-induced place preference conditioning in rats
-
Papp M. Differential effects of short-and long-term antidepressant treatments on the food-induced place preference conditioning in rats. Behav. Pharmacol. 1 (1989) 69-74
-
(1989)
Behav. Pharmacol.
, vol.1
, pp. 69-74
-
-
Papp, M.1
-
21
-
-
0026512239
-
Opioid and non-opioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic
-
Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., and Vaught J.L. Opioid and non-opioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J. Pharmacol. Exp. Ther. 260 (1992) 275-285
-
(1992)
J. Pharmacol. Exp. Ther.
, vol.260
, pp. 275-285
-
-
Raffa, R.B.1
Friderichs, E.2
Reimann, W.3
Shank, R.P.4
Codd, E.E.5
Vaught, J.L.6
-
22
-
-
0027429714
-
Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol
-
Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., Vaught J.L., Jacoby H.I., and Selve N. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J. Pharmacol. Exp. Ther. 267 (1993) 331-340
-
(1993)
J. Pharmacol. Exp. Ther.
, vol.267
, pp. 331-340
-
-
Raffa, R.B.1
Friderichs, E.2
Reimann, W.3
Shank, R.P.4
Codd, E.E.5
Vaught, J.L.6
Jacoby, H.I.7
Selve, N.8
-
23
-
-
0034333003
-
Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/1B) antagonist, enhances the analgesic effect of tramadol
-
Rojas-Corrales M.O., Ortega-Alvaro A., Gibert-Rahola J., Roca-Vinardell A., and Mico J.A. Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/1B) antagonist, enhances the analgesic effect of tramadol. Pain 88 (2000) 119-124
-
(2000)
Pain
, vol.88
, pp. 119-124
-
-
Rojas-Corrales, M.O.1
Ortega-Alvaro, A.2
Gibert-Rahola, J.3
Roca-Vinardell, A.4
Mico, J.A.5
-
24
-
-
0032481350
-
Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal
-
Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le Meur M., Roques B.P., Maldonado R., and Kieffer B.L. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal. Embo J. 17 (1998) 886-897
-
(1998)
Embo J.
, vol.17
, pp. 886-897
-
-
Simonin, F.1
Valverde, O.2
Smadja, C.3
Slowe, S.4
Kitchen, I.5
Dierich, A.6
Le Meur, M.7
Roques, B.P.8
Maldonado, R.9
Kieffer, B.L.10
-
25
-
-
0030949768
-
The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia
-
Sora I., Funada M., and Uhl G.R. The mu-opioid receptor is necessary for [D-Pen2,D-Pen5]enkephalin-induced analgesia. Eur. J. Pharmacol. 324 (1997) R1-R2
-
(1997)
Eur. J. Pharmacol.
, vol.324
-
-
Sora, I.1
Funada, M.2
Uhl, G.R.3
-
26
-
-
0031030042
-
Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia
-
Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., and Uhl G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 1544-1549
-
(1997)
Proc. Natl. Acad. Sci. U.S.A.
, vol.94
, pp. 1544-1549
-
-
Sora, I.1
Takahashi, N.2
Funada, M.3
Ujike, H.4
Revay, R.S.5
Donovan, D.M.6
Miner, L.L.7
Uhl, G.R.8
-
27
-
-
0035010041
-
Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve
-
Sora I., Elmer G., Funada M., Pieper J., Li X.F., Hall F.S., and Uhl G.R. Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve. Neuropsychopharmacology 25 (2001) 41-54
-
(2001)
Neuropsychopharmacology
, vol.25
, pp. 41-54
-
-
Sora, I.1
Elmer, G.2
Funada, M.3
Pieper, J.4
Li, X.F.5
Hall, F.S.6
Uhl, G.R.7
-
28
-
-
0036137094
-
In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol
-
Sprague J.E., Leifheit M., Selken J., Milks M.M., Kinder D.H., and Nichols D.E. In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol. Synapse 43 (2002) 118-121
-
(2002)
Synapse
, vol.43
, pp. 118-121
-
-
Sprague, J.E.1
Leifheit, M.2
Selken, J.3
Milks, M.M.4
Kinder, D.H.5
Nichols, D.E.6
-
29
-
-
0842266611
-
Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study
-
Tamaskar R., Parran Jr. T.V., Heggi A., Brateanu A., Rabb M., and Yu J. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study. J. Addict. Dis. 22 (2003) 5-12
-
(2003)
J. Addict. Dis.
, vol.22
, pp. 5-12
-
-
Tamaskar, R.1
Parran Jr., T.V.2
Heggi, A.3
Brateanu, A.4
Rabb, M.5
Yu, J.6
-
30
-
-
0032436807
-
Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues
-
Tzschentke T.M. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56 (1998) 613-672
-
(1998)
Prog. Neurobiol.
, vol.56
, pp. 613-672
-
-
Tzschentke, T.M.1
-
31
-
-
0037162627
-
Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol
-
Tzschentke T.M., Bruckmann W., and Friderichs E. Lack of sensitization during place conditioning in rats is consistent with the low abuse potential of tramadol. Neurosci. Lett. 329 (2002) 25-28
-
(2002)
Neurosci. Lett.
, vol.329
, pp. 25-28
-
-
Tzschentke, T.M.1
Bruckmann, W.2
Friderichs, E.3
-
32
-
-
0000811019
-
The evaluation of the analgesic action of pethidine hydrochloride (demerol)
-
Woolfe G., and MacDonald A. The evaluation of the analgesic action of pethidine hydrochloride (demerol). J. Pharmacol. Exp. Ther. 80 (1944) 300-307
-
(1944)
J. Pharmacol. Exp. Ther.
, vol.80
, pp. 300-307
-
-
Woolfe, G.1
MacDonald, A.2
-
33
-
-
0017883434
-
Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys
-
Yanagita T. Drug dependence potential of 1-(m-methoxyphenyl)-2-dimethylaminomethyl)-cyclohexan-1-ol hydrochloride (tramadol) tested in monkeys. Arzneimittelforschung 28 (1978) 158-163
-
(1978)
Arzneimittelforschung
, vol.28
, pp. 158-163
-
-
Yanagita, T.1
-
34
-
-
0033198831
-
Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice
-
Zhu Y., King M.A., Schuller A.G., Nitsche J.F., Reidl M., Elde R.P., Unterwald E., Pasternak G.W., and Pintar J.E. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 24 (1999) 243-252
-
(1999)
Neuron
, vol.24
, pp. 243-252
-
-
Zhu, Y.1
King, M.A.2
Schuller, A.G.3
Nitsche, J.F.4
Reidl, M.5
Elde, R.P.6
Unterwald, E.7
Pasternak, G.W.8
Pintar, J.E.9
|